Company Overview and News

 
DoubleDragon follow-on offering OK’d

3h business.inquirer.net
Property developer DoubleDragon Properties has obtained clearance from the Securities and Exchange Commission to embark on a P7.5-billion follow-on offering.
Upvote Downvote

 
Bargain-hunting lifts market; PSEi up 0.58%

3h business.inquirer.net
The local stock barometer climbed back to the 7,700 mark on Friday as the previous day’s bloodbath attracted bargain-hunting, mostly among domestic investors.
Upvote Downvote

 
Central bank seeks to assure amid market turbulence

7h bworldonline
CURRENT monetary policy settings remain appropriate despite some turbulence in local financial markets, the Bangko Sentral ng Pilipinas (BSP) chief said on Friday.
Upvote Downvote

 
PNB raises $300M from medium-term note issue at 4.25%

8h bworldonline
THE Philippine National Bank (PNB) raised $300 million from the issue of medium-term notes, which met with strong demand from foreign investors, it said on Friday.
Upvote Downvote

 
BDO Q1 net profit flat; sets 2018 guidance at P31-B

8h bworldonline
BDO Unibank, Inc. said net profit was little changed in the first quarter at P5.9 billion, behind the pace on its full-year profit guidance of P31 billion.
Upvote Downvote

 
BDO profit steady in first quarter

17h bworldonline
Sy-led BDO Unibank, Inc. reported flat growth in its net income during the first quarter, as the bank sets sights to rake in P31 billion for 2018.
Upvote Downvote

 
PH stocks tumble on investor jitters over growing risks

2018-04-19 business.inquirer.net
The local stock market tumbled sharply on Thursday, underperforming regional markets, as investors dumped equities due to escalating concerns over local economic “overheating” risks and the US-China trade war.
Upvote Downvote

 
Peso weakens as stocks sink to new low intraday

2018-04-19 bworldonline
The local currency ended at P52.10 versus the greenback, three centavos weaker than its P52.07-per-dollar finish on Wednesday.
Upvote Downvote

 
PSEi slides on “overheating” fears

2018-04-19 business.inquirer.net
The local stock market tumbled sharply on Thursday, underperforming regional markets, as investors dumped equities due to escalating concerns on local economic “overheating” risks and US-China trade war.
Upvote Downvote

 
Peso dips after Philippine stocks plummet

2018-04-19 bworldonline
The peso weakened against the dollar on Thursday, April 19, as the local bourse dipped intraday.
Upvote Downvote

 
PSEi halts slide as investors go for large cap stocks

2018-04-18 business.inquirer.net
The stock barometer rebounded on Wednesday following a three-day slump as foreign funds sifted through the rubble of large cap stocks.
Upvote Downvote

 
ALI plans KL residential project

2018-04-18 bworldonline
AYALA LAND, Inc. (ALI) is furthering its international ambition with the acquisition of a four-hectare property in Malaysia’s capital city for P2 billion, seeking to transform it into a residential area.
Upvote Downvote

 
PSEi halts losing streak on bargain hunting

2018-04-18 bworldonline
SHARE prices halted a three-day run of declines on Wednesday, as investors sought bargains as global markets provided cause for optimism overnight.
Upvote Downvote

 
Stocks snap three-day decline on Wall Street gains, bargain hunting

2018-04-18 bworldonline
The local barometer for investor confidence snapped its three-day decline on Wednesday, April 18, fuelled by investors looking for bargains alongside optimism from global markets overnight.
Upvote Downvote

 
Radisson RED debuts in PH

2018-04-18 business.inquirer.net
Property developer Cebu Landmasters is expanding its hotel footprint by investing in a 146-room new hotel under the Radisson RED brand in Mandaue, Cebu which will open by 2021.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...